RSS-Feed abonnieren
DOI: 10.1055/s-0031-1273207
© Georg Thieme Verlag KG Stuttgart · New York
Langzeitverlauf 10 Jahre nach transpupillarer Thermotherapie (TTT) kleiner, posteriorer maligner Aderhautmelanome
Long-Term Follow-Up 10 Years after Transpupillary Thermotherapy (TTT) for Small, Posterior Located Malignant Melanomas of the ChoroidPublikationsverlauf
Eingegangen: 12.9.2010
Angenommen: 13.9.2010
Publikationsdatum:
11. April 2011 (online)

Zusammenfassung
Hintergrund: Auswertung von Langzeitergebnissen der transpupillaren Thermotherapie (TTT) zur Primärbehandlung kleiner maligner Aderhautmelanome. Patienten und Methoden: In einer prospektiven, nicht randomisierten Interventionsstudie wurden 26 Augen mit kleinen posterioren malignen Aderhautmelanomen (zentral des Äquators gelegen mit einer Basis ≤ 12 und Prominenz ≤ 4,5 mm) im Zeitraum 1/1998 bis 10/1999 mit transpupillarer Thermotherapie nach Standardprotokoll behandelt und über mehr als 10 Jahre nachkontrolliert. Ergebnisse: 13 Männer und 13 Frauen wurden mit TTT behandelt (Altersmedian 64 Jahre). Die Tumorausgangsprominenz betrug im Median 2,45 mm (0,8 – 4,5 mm). Die Nachuntersuchung 10 Jahre postoperativ ergab nach im Median 1,4 TTT-Behandlungen eine komplette Tumorregression ohne Rezidiv in 16 / 26 Augen, eine primäre lokale Tumorkontrolle mit späterem Rezidiv in 6 / 26 Augen und fehlende primäre Tumorkontrolle in 4 / 26 Augen. 2 Patienten verstarben im Beobachtungszeitraum tumorbedingt mit Lebermetastasierung. 14 Augen (vorwiegend bei Tumorlage am hinteren Pol und nach mehr als einer TTT-Behandlung) entwickelten okuläre Komplikationen: Makular Pucker in 8, Makulaödem in 6, choroidale Neovaskularisationen in 4 und posteriore Synechien mit Irisatrophie in einem Auge. Schlussfolgerung: Maligne Aderhautmelanome, die mit TTT als alleinigem Therapieverfahren behandelt wurden, zeigen im Langzeitverlauf hohe Raten von lokalen Tumorrezidiven und okulären Komplikationen. Ein enges Monitoring für alle so behandelten Patienten ist daher lebenslang zwingend notwendig.
Abstract
Background: The aim of this study was to evaluate the long-term results of transpupillary thermotherapy (TTT) for small malignant choroidal melanomas. Patients and Methods: In the time period 1/1998 to 10/1999 in a prospective non-randomised analysis 26 eyes with small malignant melanomas (located posterior to the equator with base ≤ 12 and thickness ≤ 4.5 mm) were primary treated with the TTT standard protocol (follow-up over a time span of at least 10 years). Results: Thirteen women and thirteen men (mean age: 64 years) underwent TTT. The mean preoperative tumour thickness was 2.45 mm (0.8 – 4.5 mm). Ten years postoperatively tumour regression without recurrence after 1.4 treatment sessions (mean) was achieved in 16 / 26 eyes, primary regression followed by tumour regrowth in 6 / 26 eyes, and primary failure of tumour regression in 4 / 26 eyes. Two patients died on liver metastasis. Ocular complications (with preference in posterior tumours after multiple TTT sessions) were observed in 14 eyes: macular pucker in 8, macular oedema in 6, choroidal neovascularisation in 4 and posterior synechia with iris atrophy in one eye. Conclusions: Choroidal melanomas treated with TTT as a stand-alone procedure need a close monitoring since these tumours developed a significant rate of local recurrences and ocular side-effects in the long run.
Schlüsselwörter
malignes Aderhautmelanom - transpupillare Thermotherapie - Langzeitverlauf - Tumorrezidive - okuläre Komplikationen
Key words
malignant choroidal melanoma - transpupillary thermotherapy - long-term follow-up - tumour reccurrence - ocular side-effects
Literatur
- 1
Aaberg T M Jr, Bergstrom C S, Hickner Z J et al.
Long-term results of primary transpupillary thermal therapy for the treatment of choroidal
malignant melanoma.
Br J Ophthalmol.
2008;
92 (6)
741-746
MissingFormLabel
- 2
Cruess A F, Augsburger J J, Shields J A et al.
Regression of posterior uveal melanomas following cobald-60 plaque radiotherapy.
Ophthalmology.
1984;
91
1716-1719
MissingFormLabel
- 3
Currie Z I, Rennie I G, Talbot J F.
Retinal vascular changes associated with transpupillary thermotherapy for choroidal
melanomas.
Retina.
2000;
20
620-626
MissingFormLabel
- 4
Diaz C E, Capone A, Grossniklaus H E.
Clinicopathologic findings in recurrent choroidal melanoma after transpupillary thermotherapy.
Ophthalmology.
1998;
105
1419-1424
MissingFormLabel
- 5
Finger P T.
Radiation Therapy for Choroidal Melanoma.
Surv Ophthalmol.
1997;
42 (3)
215-232
MissingFormLabel
- 6
Finger P T, Lipka A C, Lipkowitz J L et al.
Failure of transpupillary thermotherapy (TTT) for choroidal melanoma: two cases with
histopathological correlation.
Br J Ophthalmol.
2000;
84
1075-1076
MissingFormLabel
- 7
Gruterich M, Mueller A J, Ulbig M et al.
What is the value of transpupillary thermotherapy in treatment of flat posterior choroid
melanomas.A sytematic review of the literature.
Klin Monatsbl Augenheilkd.
1999;
215 (3)
147-151
MissingFormLabel
- 8
Harbour J W, Meredith T A, Thompson P A et al.
Transpupillary thermotherapy versus plaque radiotherapy for suspected choroidal melanomas.
Ophthalmology.
2003;
110 (11)
2207-2214
MissingFormLabel
- 9
Journée-Korver J G, Oosterhuis J A, Wolff-Rouendaal de D et al.
Histopathological findings in human choroidal melanomas after transpupillary thermotherapy.
Br J Ophthalmol.
1997;
81
234-239
MissingFormLabel
- 10
Keunen de J EE, Journée-Korver J G, Oosterhuis J A.
Transpupillary thermotherapy of choroidal melanoma with or without brachytherapy:
A dilemma.
Br J Ophthalmol.
2000;
84
1075-1076
MissingFormLabel
- 11 Langmann de G, Kleinert R, Faulborn J. Transpupillary Diode Laser Hyperthermia – Histopathologic Finding of Eyes with Melanoma
and First Clinical Results. Vortrag auf der Jahrestagung der Retinologischen Gesellschaft München; Juni/1996
MissingFormLabel
- 12 Leeper D. Molecular and cellular mechanism of hyperthermia alone or combined with other modalities. In: Overgaard J, ed. Hyperthermic Oncology.. 2 London, England: Taylor & Francis Ltd; 1985: 9-40
MissingFormLabel
- 13
Lommatzsch P K.
Results after Beta-irradiation (Ru-106 /Rh-106) of choroidal melanomas: 20 year’s
experience.
Br J Ophthalmol.
1986;
70
844-851
MissingFormLabel
- 14
MacFaul P A, Morgan G.
Histopathological changes in malignant melanoma of the choroid after cobald plaque
therapy.
Br J Ophthalmol.
1977;
61
221-228
MissingFormLabel
- 15
Nuijs-Beems E M, Oosterhuis J A, Verburg-Marel E H et al.
Tumor destruction by intermediate level hyperthermia.
Curr Eye Res.
1990;
9
771-780
MissingFormLabel
- 16
Oosterhuis J A, Journée-Korver de H G, Kakebeeke-Kemme H M et al.
Transpupillary thermotherapy in choroidal melanomas.
Arch Ophthalmol.
1995;
113
315-321
MissingFormLabel
- 17
Oosterhuis J A, Journee-Korver de H G, Keunen J EE.
Transpupillary thermotherapy. Results in 50 patients with choroidal melanoma.
Arch Ophthalmol.
1998;
116
157-162
MissingFormLabel
- 18
Pan van der Y, Diddie K, Lim J I.
Primary transpupillary thermotherapy for small choroidal melanomas.
Br J Ophthalmol.
2008;
92 (6)
747-750
MissingFormLabel
- 19
Parrozzani R, Boccassini B, De Belvis V et al.
Long-term outcome of transpupillary thermotherapy as primary treatment of selected
choroidal melanoma.
Acta Ophthalmol.
2008;
[Epub ahead of print]
MissingFormLabel
- 20
Pilotto E, Vujosevic S, De Belvis V et al.
Long-term choroidal vascular changes after iodine brachytherapy versus transpupillary
thermotherapy for choroidal melanoma.
Eur J Ophthalmol.
2009;
19 (4)
646-653
MissingFormLabel
- 21
Reinhold H S, Endrich B.
Invited review: tumor microcirculation as a target for hyperthermia.
Int J Hyperthermia.
1986;
2
111-137
MissingFormLabel
- 22
Robertson D M, Buettner H, Bennett S R.
Transpupillary thermotherapy as primary treatment for small choroidal melanomas.
Arch Ophthalmol.
1999;
117
1512-1519
MissingFormLabel
- 23
Rotman M, Long R S, Packer S et al.
Radiation therapy of choroidal melanoma.
Trans Ophthalmol Soc U K.
1977;
97
431-435
MissingFormLabel
- 24
Shields C L, Shields J A, Kiratli H et al.
Risk factors for growth and metastasis of small choroidal melanocytic lesions.
Ophthalmology.
1995;
102
1351-1361
MissingFormLabel
- 25 Shields C L. Clinical evaluation of choroidal tumors. In: Yanuzzi L A, Flower R W, Slakter J S, (eds.) Indocyanine Green Angiography.. St. Louis: Mosby; 1997: 271-295
MissingFormLabel
- 26
Shields C L, Cater J, Shields J A et al.
Combination of clinical factors predictive of growth of small choroidal melanocytic
tumors.
Arch Ophthalmol.
2000;
118
360-364
MissingFormLabel
- 27
Shields C L, Shields J A, Perez N et al.
Primary transpupillary thermotherapy for small choroidal melanoma in 256 consecutive
cases.
Ophthalmology.
2002;
109
225-234
MissingFormLabel
- 28
Shields J A, Augsburger J J, Brady L W et al.
Cobald plaque therapy for posterior uveal melanomas.
Ophthalmology.
1982;
89
1201-1207
MissingFormLabel
- 29
Singh A D, Kivelä T, Seregard S et al.
Primary transpupillary thermotherapy of „small” choroidal melanoma: is it safe ?.
Br J Ophthalmol.
2008;
92 (6)
727-728
MissingFormLabel
- 30
Song C W.
Effect of local hyperthermia on blood flow and microenvironment: a review.
Cancer Res.
1984;
44 (Suppl)
4721-4730
MissingFormLabel
- 31
Stoffelns B M, Kutzner J, Schoepfer K et al.
Prospective nonrandomized analysis of „sandwich therapy” for malignant melanomas of
the choroid.
Klin Monatsbl Augenheilkd.
2002;
219 (4)
211-215
MissingFormLabel
- 32
Stoffelns B M.
Primary transpupillary thermotherapy (TTT) for malignant choroidal melanoma.
Acta Ophthalmol Scand.
2002;
80 (1)
25-31
MissingFormLabel
- 33
Stoffelns B M.
Morphologische und funktionelle Ergebnisse nach transpupillarer Thermotherapie (TTT)
maligner Aderhautmelanome.
Klin Monatsbl Augenheilkd.
2006;
223
74-80
MissingFormLabel
- 34
Win P H, Robertson D M, Buettner H et al.
Extended follow-up of small melanocytic choroidal tumors treated with transpupillary
thermotherapy.
Arch Ophthalmol.
2006;
124 (4)
503-506
MissingFormLabel
- 35
Yarovoy A A, Magaramov D A, Bulgakova E S.
Which choroidal melanoma should be treated with primary transpupillary thermotherapy?
Our experience from 78 patients.
Eur J Ophthalmol.
2010;
20 (1)
186-193
MissingFormLabel
PD Dr. Bernhard Stoffelns
Augenklinik der Universitätsmedizin, Johannes Gutenberg-Universität
Langenbeckstrasse 1
55131 Mainz
Telefon: ++ 49/61 31/1 77 1 33
Fax: ++ 49/61 31/1 76 6 20
eMail: bernhard.stoffelns@unimedizin-mainz.de